Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)

CNY 25.56

(1.43%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.78 Billion 3.42 Billion 3.37 Billion 3.78 Billion 3.17 Billion 2.92 Billion
Total Current Assets 1.22 Billion 1.01 Billion 947.82 Million 1.8 Billion 2.09 Billion 1.94 Billion
Cash And Short Term Investments 626.6 Million 625.61 Million 608.12 Million 1.52 Billion 1.8 Billion 1.68 Billion
Cash and Cash Equivalents 230.2 Million 345.24 Million 599.08 Million 1.34 Billion 1.8 Billion 1.68 Billion
Short Term Investments 396.4 Million 280.37 Million 9.03 Million 181.36 Million 2 Million -1.34 Million
Net Receivables 330.46 Million 335.6 Million 272.77 Million 242.52 Million 276.03 Million 242.04 Million
Inventory 48.46 Million 36.99 Million 47.02 Million 33.94 Million 14.25 Million 9.62 Million
Other Current Assets 224.41 Million 18.49 Million 19.9 Million 3.74 Million 3.11 Million 3 Million
Total Non-Current Assets 2.55 Billion 2.4 Billion 2.42 Billion 1.97 Billion 1.07 Billion 975.69 Million
Net PPE 414.54 Million 440.14 Million 406.89 Million 328.62 Million 348.89 Million 369.67 Million
Good Will And Intangible Assets 1.1 Billion 1.02 Billion 993.88 Million 916.86 Million 60.3 Million 80.43 Million
Good Will 97.64 Million 97.64 Million 97.64 Million 98.64 Million - -
Intangible Assets 1 Billion 931.51 Million 896.23 Million 818.21 Million 60.3 Million 80.43 Million
Long-Term Investments 412.44 Million 393.57 Million 686.9 Million 504.13 Million 650.22 Million 515.09 Million
Tax Assets 32.27 Million 1.08 Million 8.96 Million 7.05 Million 8.29 Million 7.13 Million
Other Non Current Assets 589.5 Million 544.13 Million 326.85 Million 220.74 Million 7.76 Million 3.35 Million
Other Assets 1.00 - 1.00 1.00 - -
Total Liabilities 418.43 Million 234.67 Million 240.74 Million 701.72 Million 445.84 Million 439.47 Million
Total Current Liabilities 323.38 Million 172.36 Million 154.77 Million 595.02 Million 330.09 Million 325.56 Million
Account Payables 82.96 Million 48.47 Million 46.73 Million 108.38 Million 229.61 Million 231.07 Million
Tax Payables 3.68 Million 39.57 Million 27.3 Million 24.18 Million 30.54 Million 24.17 Million
Short Term Debt 105.99 Million 8.71 Million 7.5 Million 24.46 Million -3.56 Million -3.18 Million
Deferred Revenue 134.39 Million 2.92 Million 100.5 Million 461.86 Million 3.56 Million 3.18 Million
Other Current Liabilities 30.41 Thousand 112.25 Million 21.74 Thousand 307.05 Thousand 100.48 Million 94.48 Million
Total Non Current Liabilities 95.05 Million 62.31 Million 85.97 Million 106.7 Million 115.74 Million 113.91 Million
Long-Term Debt 43.78 Million 3.7 Million 11.12 Million - - -
Deferred Revenue Non Current 23.48 Million 28.97 Million 29.83 Million 35.73 Million 41.68 Million 46.69 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.00 1.00 1.00 - - -
Other Liabilities -0.00 - - - 1.00 -
Total Equity 3.36 Billion 3.19 Billion 3.13 Billion 3.08 Billion 2.72 Billion 2.48 Billion
Stock Holders Equity 3.05 Billion 2.92 Billion 2.88 Billion 3.07 Billion 2.72 Billion 2.48 Billion
Common Stock 160 Million 160 Million 160 Million 160 Million 160 Million 160 Million
Retained Earnings 1.97 Billion 1.85 Billion 1.79 Billion 1.7 Billion 1.47 Billion 1.28 Billion
Accumulated other comprehensive income 3.13 Billion 62.99 Million 80.39 Million 244.56 Million 110.85 Million 51.61 Million
Common Stock Equity 3.05 Billion 2.92 Billion 2.88 Billion 3.07 Billion 2.72 Billion 2.48 Billion
Capital Lease Obligation 3.95 Million 3.7 Million 11.12 Million - - -
Total Investments 808.84 Million 673.94 Million 695.94 Million 685.49 Million 652.22 Million 513.75 Million
Total Debt 149.78 Million 12.42 Million 18.62 Million 24.46 Million - -
Net Debt -80.42 Million -332.82 Million -580.45 Million -1.32 Billion -1.8 Billion -1.68 Billion

Balance Sheet Charts